As cannabis users embrace concentrates, companies are isolating chemicals to make reliable products — and it’s making weed products intellectual property
When you think of weed, you likely think of a sticky bud, an oil, maybe even a tincture. But what if you reconfigured your notion of cannabis to instead envision an abstract scientific equation? Sure, this may sound like the stuff of stoner sci-fi, except that it’s the real-life direction that the cannabis industry is headed.
That’s because the future of weed is in formulations.
So while there will always be a need for skilled cultivators to grow the plant, consumers — especially novice consumers — more and more will veer toward a manufactured cannabis oil, edibles, pills, or tinctures, designed by scientists to target the consumer’s specific needs. The basis of these products are specially curated chemical concoctions, donning specific ratios of cannabinoids (like THC and CBD) and terpenes, aromatic compounds that provide a distinct character to each of marijuana’s varied psychoactive effects.
As adult-use and medical-marijuana policies become more commonplace, the canna-curious demographic is growing. Whether these naive consumers are interested in cannabis for its therapeutic or recreational benefits, many are not up for the gamble of smoking flower to see what happens. [Read More @ Rolling Stone]
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers